DOH to monitor 205,000 children vaccinated with Dengvaxia in Region 3

UNTV News   •   December 7, 2017   •   5735

IMAGE_UNTV_NEWS_120617_Close Monitoring

MANILA, Philippines — The Department of Health (DOH) met with the Municipal Health Officers in Region 3, Wednesday, to discuss the measures they are going to take concerning children who have already been vaccinated with Dengvaxia.

DOH Region 3 Director Dr. Leonita Gorgolon said they will monitor and survey these children one by one to determine if they had experienced negative side effects.

“So hahanapin po namin ngayon (we will track them). We will issue advisory to all RHUs (rural health units) and the district hospital and regional hospital to be alert on especially grade 4 students with fever to make sure na, matanong talaga sila (to ask them). Very important question is: did they receive previous vaccine especially Dengvaxia? ” Gorgolon said.

Based on DOH Region 3 records, the number of children who have undergone anti-dengue vaccination reached 205,000.

Aside from monitoring, the DOH will also look into the sanitation in the region to prevent breeding of dengue-carrying mosquitos.

DOH Region 3 also plans to provide parents a thorough explanation of the controversy surrounding Dengvaxia.

The agency also ensured to give the necessary assistance to whoever will experience the side effects of the said vaccine.

“I would like also to emphasize that in any event we are ready to help kung kailangan namin talagang tulungan yung family to make sure na walang mawawala,(if the family will require assistance to make sure no one dies [from side effects]) we will do that,” said Gorgolon.

The DOH once again assured that they are doing everything to determine who are responsible for the distribution of Dengvaxia and how this issue can be solved.

“For the last past few days talaga nirereview yung mga dokumentong mayroon tayo, yung mga papel na hawak natin yung mga prosesong dinaanan sa pagpoprocure, yung pagpaplano yung mga ginawang exchange sa mga experts, titingnan kung may gaps dito, nagkaroon ba ng lapse,” Assistant Secretary of Health Dir. Dr. Lyndon L. Lee Suy said.

(For the last past few days we have been reviewing the documents that we have, the processes of procurement, the planning, the exchanges with experts. We will check if there were gaps and lapses.) – Joan Nano | UNTV News & Rescue

DOH agrees with FDA decision to ban Dengvaxia in Phl

Maris Federez   •   August 22, 2019

A Filipino nurse prepares to administer an anti-dengue vaccine during a nationwide vaccination at a school in the flood-prone city of Marikina, east of Manila, Philippines, 04 April 2016. (Photoville International / FILE)

The Department of Health (DOH) has rejected the request of Sanofi Pasteur to overturn the decision of the Food and Drug Administration (FDA) to ban the use of Dengvaxia vaccine in the Philippines.

With this, the DOH approved the ruling of the FDA to permanently revoke the certificate of product registration of Dengvaxia for Sanofi’s failure to submit the necessary post-approval requirements.

“The decision concerns Sanofi’s complete disregard of FDA regulations, which were precisely put in place by law to ensure safety,” DOH Secretary Francisco Duque III said in a statement.

Although Sanofi was able to submit the first two versions of its risk management plans (RMP), the pharmaceutical company failed to submit the third and final version of the plan.

The DOH said, however, that Sanofi may apply for a new certificate of product registration (CPR) for Dengvaxia but this must be in accordance with the FDA regulations.

“Given that Dengvaxia is an innovative drug, the importance of complying with these post-marketing commitments is critical to public safety,” the statement added.

Meanwhile, the department has assured that it continues to address the increasing cases of dengue in the country. /mbmf

DOH Region 3: Over 100 Chinese workers, now dengue free

Aileen Cerrudo   •   August 21, 2019

The Department of Health (DOH) Region 3 has reported that the over 100 Chinese workers who contracted dengue in Morong, Bataan are now free of the disease.

The Chief of the Regional Epidemiology Surveillance Unit of DOH Region 3 Dr. Jessie Fantone said 69 of the Chinese workers have contracted dengue last March. The remaining 35 were reported to have contracted the diseases this August.

“All of them got well and wala namang namatay. Kaya lang noong pinuntahan namin iyong plant nila marami silang areas na stagnant water na breeding sites (There were no fatalities, but when we visited their plant, there was a lot of stagnant water which can be become breeding sites),” he said.

Meanwhile, cleaning operations continue at the barangay where the coal plant is located.—AAC (with reports from Aiko Miguel)

Sanofi Pasteur optimistic Dengvaxia will be restored in PH market

Aileen Cerrudo   •   August 15, 2019

French Pharmaceutical firm, Sanofi Pasteur expressed optimism that the Dengvaxia vaccine will be restored in the Philippine market.

In a statement, Sanofi Pasteur Philippines General Manager Jean Antoine Zinsou said they are open for a discussion with the Food and Drug Administration (FDA) and the Department of Health (DOH).

He also clarified that Dengvaxia is safe and effective to use.

According to Zinsou, the said vaccine was only banned in the Philippines because of incomplete documents or due to “administrative consideration.”

“We definitely need to settle this issue. One way to do it is to discuss with FDA and see what is needed to have this revocation lifted,” he said.

Zinsou also said Dengvaxia is registered in 20 countries across the globe and is acknowledged by the United States Food Drug Administration and the World Health Organization (WHO).

Meanwhile, Sanofi agrees with the DOH that Dengvaxia is not a solution to the Dengue epidemic in the country.

READ: Dengvaxia won’t bring dengue cases down – DOH

“The vaccines that we are mentioning is not a solution or a silver bullet for the ongoing outbreak. We are open to any discussion with the health authorities to see what is needed, what do they need for the future,” Zinsou said.

In February this year, the FDA revoked the certificate of product registration of Dengvaxia.

Sanofi already filed an appeal two weeks ago and the DOH will release their decision on the issue on August 19.—AAC (with reports from Aiko Miguel)

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+63) 396-8688 (Tel)

(+63) 2 920.8336 (Fax)

info@untvweb.com (General inquiries)

support@untvweb.com

UNTV News and Rescue Emergency Hotlines:

LANDLINE (+63) 396-8688

ADVERTISE WITH US

(+63) 2 442.6244 Loc. 143, 144, 162, 164

advertising@untvweb.com

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.